Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02336984
Title A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS
Recruitment Withdrawn
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

Her2-receptor positive breast cancer

Therapies

Trastuzumab

HER2-pulsed DC1 vaccine

Age Groups: adult
Covered Countries USA


No variant requirements are available.